Clinical analysts demonstrate against new tariffs in Italy
This article was originally published in Clinica
Clinical analysts in Italy are becoming increasingly anxious as the date approaches for the introduction of the new reimbursement levels for outpatient services, including diagnostic procedures. The National Association of Clinical Analysts chose December 5th to demonstrate against the new tariffs - which cut reimbursement by up to 40%.
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.